New hope for dialysis patients: extra filter aims to clean blood better
NCT ID NCT05639010
Summary
This study is testing if adding a weekly blood-filtering treatment (hemoperfusion) to standard dialysis helps remove more harmful waste products from the blood of people with kidney failure. Researchers will measure levels of specific substances linked to complications and check if patients feel better, sleep better, and have less itching. The goal is to see if this combined approach improves disease management and quality of life for people who rely on long-term dialysis.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for END STAGE RENAL DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Changhai Hospital
Shanghai, Shanghai Municipality, 200433, China
Conditions
Explore the condition pages connected to this study.